ReviewA review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy
Introduction
There is a considerable interest worldwide in the use of subconvulsive repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression. rTMS has excited the interest of clinicians and been highly acceptable to patients (Walter et al., 2001), because of its ability to stimulate focal areas of brain cortex non-invasively using magnetic fields. Unlike ECT, it does not involve a general anaesthetic or seizure. In some countries, e.g. Canada and Israel, rTMS is approved for the clinical treatment of depression. In Australia, the Royal Australian and New Zealand College of Psychiatrists Position Statement on TMS (2003) recognizes the need for further research into TMS but cautiously allows for its clinical use to treat depression in limited circumstances, with recommended caveats, including that the patient sign a consent form acknowledging that “the most efficacious manner of administering rTMS has not yet been established”.
The International Society for Transcranial Stimulation Consensus Statement on the use of rTMS is mainly concerned with advising on safety and procedural issues in whatever context rTMS is used (Belmaker et al., 2003). There has been a debate on the advisability of broadening the use of rTMS to clinics beyond research centres, with discussion of associated regulatory issues (e.g. Fitzgerald, 2003a, Sachdev, 2003). Apart from considerations of safety, adequate regulatory safeguards and the limitations of current therapeutic options in treatment resistant depression, a critical appraisal of the efficacy of rTMS as a treatment for depression is central to this debate. This article evaluates the efficacy outcomes reported so far in clinical trials of rTMS, and discusses the potential of future strategies to optimize the efficacy of rTMS.
Section snippets
Studies of the efficacy of rTMS in depression
Given the relatively large number of published rTMS treatment trials but relatively small sample sizes in each (see Table 1 for summary of sham-controlled trials), it is perhaps most constructive to begin by reviewing the seven published meta-analyses (including a Cochrane Review) (McNamara et al., 2001, Holtzheimer et al., 2001, Burt et al., 2002, Kozel and George, 2002, Martin et al., 2003, Aarre et al., 2003, Couturier, 2005).
The earliest meta-analysis (McNamara et al., 2001) only included
Strategies to optimize the efficacy of rTMS
As can be seen from Table 1, studies have varied greatly in the choice of rTMS parameters used (stimulus frequency (i.e. number of pulses per second), intensity, number of stimuli), with an even larger range of possible combinations of these. Almost no two studies have used identical rTMS parameters, except in deliberate attempts at replication, making comparisons of efficacy difficult. As yet, there is little empirical evidence to guide the choice of these parameters.
Conclusion
Most of the sham-controlled data for the efficacy of rTMS in treating depression comes from studies with a two-week sham-controlled period. The outcomes suggest clear statistical proof of superiority over placebo effects but not large clinical effects. However, the few studies which have reported results of longer periods of stimulation suggest that a longer course of rTMS is necessary for optimal therapeutic outcomes. Thus evidence for the efficacy of rTMS should be derived from
Acknowledgements
Dr. Loo is a part-time Senior Research Fellow supported by a National Health and Medical Council Program Grant no. 2223208. The authors thank Kate Manollaras for assistance in manuscript preparation.
References (73)
- et al.
A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression
Biological Psychiatry
(2000) - et al.
Slow magnetic stimulation of prefrontal cortex in depression and schizophrenia
Progress in Neuro-Psychopharmacology and Biological Psychiatry
(1997) - et al.
A controlled trial of daily left prefrontal cortex TMS for treating depression
Biological Psychiatry
(2000) - et al.
Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study
Biological Psychiatry
(2000) - et al.
A randomised controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression
Biological Psychiatry
(2003) - et al.
Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial
Biological Psychiatry
(2002) - et al.
Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study
Biological Psychiatry
(2004) - et al.
Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials
Biological Psychiatry
(2001) - et al.
Transcranial magnetic stimulation (TMS) in controlled treatment studies: are some “sham” forms active?
Biological Psychiatry
(2000) - et al.
Repetitive transcranial magnetic stimulation (rTMS) at high and low frequency: an efficacious therapy for major drug-resistant depression?
Clinical Neurophysiology
(2005)
Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients
Psychiatry Research
Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS
Psychiatry Research
Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity
Neuropsychopharmacology
Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression
The Lancet
Effectiveness of electroconvulsive therapy in community settings
Biological Psychiatry
Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study
Biological Psychiatry
Effects of different frequencies of transcranial magnetic stimulation (TMS) on the forced swim test model of depression in rats
Biological Psychiatry
Left dorso-lateral repetitive transcranial magnetic stimulation affects cortical excitability and functional connectivity, but does not impair cognition in major depression
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Time course of improvement under antidepressant treatment: a survival-analytical approach
European Journal of Neuropsychopharmacology
Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5–7, 1996
Electroencephalography and Clinical Neurophysiology
Efficacy of repetitive transcranial magnetic stimulation in depression: a review of evidence
Nordic Journal of Psychiatry
Electroconvulsive Therapy (4th edn)
An introduction to the basic principles of magnetic nerve stimulation
Journal of Clinical Neurophysiology
Managing the risks of repetitive transcranial stimulation
CNS Spectrums
Neuropsychiatric applications of transcranial magnetic stimulation: a meta-analysis
International Journal of Neuropsychopharmacology
Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation
Neurology
Flip side of synaptic plasticity: long term depression mechanisms in the hippocampus
Hippocampus
Antidepressant effects of different schedules of repetitive transcranial magnetic stimulation vs. clomipramine in patients with major depression: relationship to changes in cortical excitability
International Journal of Neuropsychopharmacology
Combining high and low frequencies in rTMS antidepressive treatment: preliminary results
Human Psychopharmacology
Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis
Journal of Psychiatry and Neuroscience
Transcranial magnetic stimulation in patients with bipolar depression: a double blind, controlled study
Bipolar Disorders
Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson's disease: an open study
Movement Disorders
Does clinical response to repetitive prefrontal transcranial magnetic stimulation (rTMS) predict response to electroconvulsive therapy (ECT) in cases of major depression?
Canadian Journal of Psychiatry
Preliminary evidence for a beneficial effect of low-frequency, repetitive transcranial magnetic stimulation in patients with major depression and schizophrenia
Depression and Anxiety
The use of rapid-rate transcranial magnetic stimulation (rTMS) in refractory depressed patients
Journal of Neuropsychiatry and Clinical Neurosciences
Cited by (261)
Transcranial magnetic stimulation for treatment-resistant depression
2022, Managing Treatment-Resistant Depression: Road to Novel Therapeutics